Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


Th17 Cell Plasticity and Functions in Cancer Immunity.

Guéry L, Hugues S.

Biomed Res Int. 2015;2015:314620. doi: 10.1155/2015/314620. Epub 2015 Oct 25. Review.


Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML Cells.

Yang FL, Chen FZ, Wan XX, Zhou X, Zhou MJ, Chen HC, Fu JJ, Zhang DZ.

Biomed Res Int. 2015;2015:325026. doi: 10.1155/2015/325026. Epub 2015 Sep 1.


Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.

Aris M, Barrio MM.

Front Immunol. 2015 Feb 9;6:46. doi: 10.3389/fimmu.2015.00046. eCollection 2015. Review.


Insights into cytokine-receptor interactions from cytokine engineering.

Spangler JB, Moraga I, Mendoza JL, Garcia KC.

Annu Rev Immunol. 2015;33:139-67. doi: 10.1146/annurev-immunol-032713-120211. Epub 2014 Dec 10.


Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.

Young PA, Morrison SL, Timmerman JM.

Semin Oncol. 2014 Oct;41(5):623-36. doi: 10.1053/j.seminoncol.2014.08.002. Epub 2014 Aug 12. Review.


Porcine sapovirus replication is restricted by the type I interferon response in cell culture.

Hosmillo M, Sorgeloos F, Hiraide R, Lu J, Goodfellow I, Cho KO.

J Gen Virol. 2015 Jan;96(Pt 1):74-84. doi: 10.1099/vir.0.071365-0. Epub 2014 Oct 10.


Human interferon alpha-2b: a therapeutic protein for cancer treatment.

Asmana Ningrum R.

Scientifica (Cairo). 2014;2014:970315. doi: 10.1155/2014/970315. Epub 2014 Mar 10. Review.


Hairy cell leukemia: short review, today's recommendations and outlook.

Maevis V, Mey U, Schmidt-Wolf G, Schmidt-Wolf IG.

Blood Cancer J. 2014 Feb 14;4:e184. doi: 10.1038/bcj.2014.3.


Type I interferons: key players in normal skin and select cutaneous malignancies.

Ismail A, Yusuf N.

Dermatol Res Pract. 2014;2014:847545. doi: 10.1155/2014/847545. Epub 2014 Jan 5. Review.


Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo.

Li M, Rao C, Pei D, Wang L, Li Y, Gao K, Wang M, Wang J.

Cancer Cell Int. 2014 Jan 27;14(1):8. doi: 10.1186/1475-2867-14-8.


Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.

Booy S, van Eijck CH, Dogan F, van Koetsveld PM, Hofland LJ.

J Cell Mol Med. 2014 Mar;18(3):492-502. doi: 10.1111/jcmm.12200. Epub 2014 Jan 25.


Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms.

Pérez C, Pascual M, Martín-Subero JI, Bellosillo B, Segura V, Delabesse E, Álvarez S, Larrayoz MJ, Rifón J, Cigudosa JC, Besses C, Calasanz MJ, Cross NC, Prósper F, Agirre X.

Haematologica. 2013 Sep;98(9):1414-20. doi: 10.3324/haematol.2013.084160. Epub 2013 May 28.


Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Fuchs SY.

J Interferon Cytokine Res. 2013 Apr;33(4):211-25. doi: 10.1089/jir.2012.0117. Review.


Type I interferons induce autophagy in certain human cancer cell lines.

Schmeisser H, Fey SB, Horowitz J, Fischer ER, Balinsky CA, Miyake K, Bekisz J, Snow AL, Zoon KC.

Autophagy. 2013 May;9(5):683-96. doi: 10.4161/auto.23921. Epub 2013 Feb 18.


Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.

Apelbaum A, Yarden G, Warszawski S, Harari D, Schreiber G.

Mol Cell Biol. 2013 Feb;33(4):800-14. doi: 10.1128/MCB.01430-12. Epub 2012 Dec 10.


N-acetylcysteine improves antitumoural response of Interferon alpha by NF-kB downregulation in liver cancer cells.

Kretzmann NA, Chiela E, Matte U, Marroni N, Marroni CA.

Comp Hepatol. 2012 Dec 4;11(1):4. doi: 10.1186/1476-5926-11-4.


Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.

Chiantore MV, Vannucchi S, Accardi R, Tommasino M, Percario ZA, Vaccari G, Affabris E, Fiorucci G, Romeo G.

PLoS One. 2012;7(5):e36909. doi: 10.1371/journal.pone.0036909. Epub 2012 May 16.


Role of the methoxy group in immune responses to mPEG-protein conjugates.

Sherman MR, Williams LD, Sobczyk MA, Michaels SJ, Saifer MG.

Bioconjug Chem. 2012 Mar 21;23(3):485-99. doi: 10.1021/bc200551b. Epub 2012 Mar 7.


Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors.

Nakashima H, Miyake K, Clark CR, Bekisz J, Finbloom J, Husain SR, Baron S, Puri RK, Zoon KC.

Cancer Immunol Immunother. 2012 Jul;61(7):1081-92. doi: 10.1007/s00262-011-1152-x. Epub 2011 Dec 13.


IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

Alexandrescu DT, Ichim TE, Riordan NH, Marincola FM, Dasanu CA.

J Immunother. 2011 Oct;34(8):607-609. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk